Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.006
▾0.001 (14.29%)
Last trade: 12/12, 3:42PM
Market cap
$9.45m
Market closed
Talk to Chimeric Therapeutics Ltd directly.
Sign up to their Investor Hub for direct access to the Chimeric Therapeutics Ltd team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Chimeric Therapeutics Limited is an Australia-based company engaged in developing CAR T cell therapies for solid tumors. The Company's technology known as CLTX-CAR T, uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. The CAR T cell is an immune T cell taken from a patient’s blood which is sent to a lab where it is re-programmed to become a charged guided missile, to seek out a specific target on the surface of a cancer cell.
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.006
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets